Apharmo Limited - Company Profile

It is a chemicals public limited company based in Chennai, Tamil Nadu, India, established in 1993.
1993 Chennai, Tamil Nadu, India Struck Off
Last Updated:
Access Report
About Apharmo Limited

Apharmo Limited, a struck off public limited company, was established on 02 July 1993 in Chennai, Tamil Nadu, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24231TN1993PLC025375. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹2.46 M.

Its leadership includes Sekar (Director), Rajasekaran (Additional Director), Sudhir Shankar Ravishankar (Additional Director). Past directors included Velu Karuppasamy, Manoharan Desamuthu, Shanmugamoorthy Subash Shankar. Its latest AGM occurred on 30 September 2009, with the balance sheet filed on 31 March 2009. It is based at No 17 ,Smv Koil Street Triplicane, Chennai, Tamil Nadu, 600005.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231TN1993PLC025375

  • Registration Number

    025375

  • Incorporation Date

    02 July 1993

  • Authorized Capital

    ₹1.50 Cr

  • Paid-Up Capital

    ₹2.46 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.50 Cr
  • Paid Up Capital ₹ 2.46 M
  • Company Age 32 Year, 7 Months
  • Last Filing with ROC 31 Mar 2009
Company report

Apharmo Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Apharmo Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Apharmo Limited?
Current Directors
Name Designation Appointment Date Status
Sekar Director 15 Jan 2010 Current
Rajasekaran Additional Director 27 Mar 2012 Current
Sudhir Shankar Ravishankar Additional Director 27 Mar 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Jan 2010 Past
Pramod Abcsdd Director 25 Jan 2010 Past
Pramod Abcsdd Director 31 Jul 2012 Past
Pramod Abcsdd Director 25 Jan 2010 Past
Pramod Abcsdd Director 31 Jul 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Apharmo.

Enhance accessibility to Apharmo's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Apharmo revenue growth over time
Apharmo profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Apharmo?

Unlock access to Apharmo's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Apharmo?

Unlock and access historical data on people associated with Apharmo, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Apharmo, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apharmo's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Apharmo
Recent Activity within the Organization
  • Director Appointment

    The activity Rajasekaran was appointed as a Additional Director was appointed as a Additional Director on 27 Mar 2012 & has been associated with this company since 13 years 11 months . was completed.

  • Director Appointment

    The activity Sudhir Shankar Ravishankar was appointed as a Additional Director was appointed as a Additional Director on 27 Mar 2012 & has been associated with this company since 13 years 11 months . was completed.

  • Director Appointment

    The activity Sekar was appointed as a Director was appointed as a Director on 15 Jan 2010 & has been associated with this company since 16 years 1 month . was completed.

  • Annual General Meeting

    The activity Apharmo Limited last Annual general meeting of members was held on 30 Sep 2009 as per latest MCA records. was completed.

  • Balance Sheet

    Apharmo Limited has filed its annual Financial statements for the year ended 31 Mar 2009 with Roc Chennai. was recorded as a recent event.

  • Company Incorporation

    The activity Apharmo Limited was registered on 02 Jul 1993 with Roc Chennai & aged 32 years 7 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Apharmo Limited?

The CIN of Apharmo Limited is U24231TN1993PLC025375.

Where is Apharmo Limited headquartered?

Apharmo Limited is headquartered at No 17 ,Smv Koil Street Triplicane, Chennai, Tamil Nadu, 600005.

When was Apharmo Limited incorporated?

Apharmo Limited was incorporated on 02 July 1993.

Who are the current directors of Apharmo Limited?

The current directors of Apharmo Limited are

What is the primary industry of Apharmo Limited?

The primary industry of Apharmo Limited is Chemicals.

Is Apharmo Limited a listed company?

Apharmo Limited is unlisted.

What is the capital structure of Apharmo Limited?

The authorized capital of Apharmo Limited is ₹1.50 Cr, and the paid-up capital is ₹2.46 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available